Minerva Neurosciences, Inc. (NERV) Is At $6.20 Formed Wedge; Lindsay (LNN)’s Sentiment Is 1.32

Minerva Neurosciences, Inc. (NERV) formed wedge down with $6.01 target or 3.00% below today’s $6.20 share price. Minerva Neurosciences, Inc. (NERV) has $239.94M valuation. The stock increased 2.48% or $0.15 during the last trading session, reaching $6.2. About 133,009 shares traded. Minerva Neurosciences, Inc. (NASDAQ:NERV) has risen 56.56% since January 3, 2017 and is uptrending. It has outperformed by 39.86% the S&P500.

Lindsay Corporation, together with its subsidiaries, provides water management and road infrastructure services and products in the United States and internationally. The company has market cap of $957.53 million. The companyÂ’s Irrigation segment makes and markets center pivot, lateral move irrigation systems, and irrigation controls under the Zimmatic brand; hose reel travelers under the Perrot and Greenfield brands; and chemical injection systems, variable rate irrigation systems, flow meters, weather stations, soil moisture sensors, and remote monitoring and control systems under the GrowSmart brand. It has a 41.16 P/E ratio. This segment also offers repair and replacement parts for irrigation systems and controls; water pumping stations and controls for agriculture, golf, landscape, and municipal markets under the Watertronics brand; filtration solutions for groundwater, agriculture, industrial, and heat transfer markets under the LAKOS brand; and M2M communication technology solutions, data acquisition and management systems, and custom electronic equipment under the Elecsys brand.

Among 3 analysts covering Minerva Neurosciences (NASDAQ:NERV), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Minerva Neurosciences had 5 analyst reports since March 9, 2016 according to SRatingsIntel. The rating was reinitiated by Jefferies on Thursday, May 12 with “Buy”. Jefferies maintained it with “Buy” rating and $17 target in Friday, May 27 report. The stock of Minerva Neurosciences, Inc. (NASDAQ:NERV) earned “Buy” rating by Citigroup on Friday, September 1. On Wednesday, March 9 the stock rating was maintained by JMP Securities with “Market Outperform”. The firm earned “Buy” rating on Thursday, June 22 by Jefferies.

Analysts await Minerva Neurosciences, Inc. (NASDAQ:NERV) to report earnings on March, 12. They expect $-0.43 earnings per share, down 59.26% or $0.16 from last year’s $-0.27 per share. After $-0.28 actual earnings per share reported by Minerva Neurosciences, Inc. for the previous quarter, Wall Street now forecasts 53.57% negative EPS growth.

John G Ullman & Associates Inc holds 2.71% of its portfolio in Lindsay Corporation for 151,191 shares. Prentiss Smith & Co Inc owns 31,477 shares or 1.74% of their US portfolio. Moreover, Impax Asset Management Ltd has 1.4% invested in the company for 495,868 shares. The Massachusetts-based Timber Creek Capital Management Llc has invested 0.89% in the stock. Shapiro Capital Management Llc, a Georgia-based fund reported 413,270 shares.

The stock increased 1.26% or $1.11 during the last trading session, reaching $89.31. About 82,778 shares traded. Lindsay Corporation (LNN) has risen 25.75% since January 3, 2017 and is uptrending. It has outperformed by 9.05% the S&P500.